Sanara MedTech's Participation at Major Healthcare Conference
Sanara MedTech Inc. (Nasdaq: SMTI), a leader in medical technology, is excited to announce its upcoming participation in a significant healthcare conference held at The Lotte New York Palace. This event showcases innovative advancements aimed at enhancing surgical outcomes and addressing healthcare costs, pivotal focus areas for the company.
Conference Details
The Piper Sandler 37th Annual Healthcare Conference will take place from December 2 to December 4. Notable for its gathering of industry leaders, the conference serves as an opportunity for Sanara's management team to share insights and developments with investors. On December 3 at approximately 9:30 a.m. Eastern Time, Sanara's leadership will present key information highlighting its strategic initiatives and product innovations designed to transform surgical care.
Innovative Solutions by Sanara MedTech
Sanara is dedicated to developing and commercializing groundbreaking technologies that improve clinical outcomes in the surgical marketplace. The company focuses on developing, marketing, and distributing high-quality surgical products that assist healthcare professionals in providing superior patient care. Sanara's product portfolio aims to achieve better clinical outcomes while simultaneously reducing overall costs associated with surgical procedures.
Product Portfolio Overview
Sanara MedTech offers a wide array of advanced solutions including CellerateRX Surgical Activated Collagen Powder, BIASURGE Advanced Surgical Solution, and FORTIFY TRG Tissue Repair Graft. These products exemplify the company's commitment to innovation. With a focus on minimally invasive techniques and enhanced recovery, each of Sanara's offerings addresses specific needs within the surgical environment.
Future Directions and Goals
Looking ahead, Sanara MedTech is poised to expand its reach within the surgical tissue repair market. The company believes it can navigate its product pipeline from concepts to preclinical and clinical stages effectively while meeting stringent quality and regulatory standards. Sanara strives to be recognized as one of the foremost providers of effective surgical solutions, constantly innovating and adapting to meet the needs of patients, especially those requiring advanced treatments in surgical environments.
Commitment to Quality and Innovation
With a firm belief that patient care should never compromise safety or efficacy, Sanara is focused on producing solutions that not only enhance recovery after surgery but also alleviate financial burdens on healthcare systems. The company understands the complexities of clinical environments and is committed to delivering solutions that align with the evolution of patient care technology.
Frequently Asked Questions
What conference is Sanara MedTech participating in?
Sanara MedTech is participating in the Piper Sandler 37th Annual Healthcare Conference.
When will Sanara MedTech present at the conference?
Sanara's presentation is scheduled for December 3 at approximately 9:30 a.m. Eastern Time.
What products does Sanara MedTech offer?
Sanara offers a variety of surgical products including CellerateRX and the FORTIFY series, designed to enhance clinical outcomes.
How does Sanara MedTech plan to innovate?
Sanara focuses on developing transformative technologies that improve patient outcomes and reduce healthcare costs.
Who can be contacted for investor relations inquiries?
For inquiries, investors can reach out to Jack Powell or Mike Piccinino, CFA at ICR Healthcare via email.